ProCE Banner Activity

Experts Answer Clinician Questions on Immunotherapy for Advanced HCC: Podcast Pearls

PDF

In this downloadable PDF transcript from a CCO podcast, Amit G. Singal, MD, MS, and Lipika Goyal, MD, answer audience questions focused on current best practices and emerging applications with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.

Released: January 21, 2021

Expiration: January 20, 2022

No longer available for credit.

Share

Faculty

Lipika Goyal

Lipika Goyal, MD, MPhil

Associate Professor in Medicine
Director of Gastrointestinal Oncology
Stanford School of Medicine
Palo Alto, California

Amit G. Singal

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group

Faculty Disclosure

Primary Author

Lipika Goyal, MD, MPhil

Associate Professor in Medicine
Director of Gastrointestinal Oncology
Stanford School of Medicine
Palo Alto, California

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas